ANTIOXIDANT THERAPY FOR IDIOPATHIC PULMONARY FIBROSIS. A PROMISING THERAPEUTIC PROSPECT

被引:0
|
作者
Tomioka, Hiromi [1 ]
机构
[1] Kobe City Med Ctr W Hosp, Dept Resp Med, Kobe, Hyogo, Japan
关键词
LOWER RESPIRATORY-TRACT; N-ACETYLCYSTEINE; GLUTATHIONE DEFICIENCY; POLYMORPHISMS; BLEOMYCIN; MICE;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:83 / 84
页数:2
相关论文
共 50 条
  • [41] Serum prealbumin as prognostic indicator in idiopathic pulmonary fibrosis. A glimmer of hope
    Aggarwal, Deepak
    CLINICAL RESPIRATORY JOURNAL, 2019, 13 (10): : 659 - 660
  • [42] Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the "bed' that counts and not "the sleepers'
    Tomos, Ioannis P.
    Tzouvelekis, Argyrios
    Aidinis, Vassilis
    Manali, Effrosyni D.
    Bouros, Evangelos
    Bouros, Demosthenes
    Papiris, Spyros A.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (04) : 299 - 309
  • [43] Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study
    Karampitsakos, Theodoros
    Gomatou, Georgia
    Tzilas, Vasilios
    Bouros, Evangelos
    Markozannes, Evangelos
    Manali, Effrosyni
    Tomos, Ioannis
    Antoniou, Katerina
    Trachalaki, Athina
    Kolilekas, Lykourgos
    Korbila, Ioanna
    Tomos, Periklis
    Chrysikos, Serafeim
    Dimakou, Katerina
    Loverdos, Konstantinos
    Gaga, Asimina
    Daniil, Zoe
    Bardaka, Fotini
    Papanikolaou, Ilias
    Papakosta, Despoina
    Markopoulou, Katerina
    Tringidou, Rodoula
    Papiris, Spyridon
    Bouros, Demosthenes
    Tzouvelekis, Argyris
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [44] Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study
    Tzouvelekis, Argyris
    Karampitsakos, Theodoros
    Gomatou, Georgia
    Tzilas, Vasilios
    Bouros, Evangelos
    Chrysikos, Serafeim
    Markozannes, Evangelos
    Kolilekas, Lykourgos
    Manali, Efrossyni
    Tomos, Ioannis
    Korbila, Ioanna
    Tomos, Periklis
    Loverdos, Konstantinos
    Gaga, Asimina
    Antoniou, Katerina
    Trachalaki, Athina
    Daniil, Zoe
    Bardaka, Fotini
    Markopoulou, Katerina
    Papiris, Spyridon
    Tringidou, Rodoula
    Bouros, Demosthenes
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [45] Antifibrotic therapy for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Teoh, A.
    Glenn, L.
    Corte, T.
    Holland, A.
    RESPIROLOGY, 2023, 28 : 202 - 202
  • [46] Promising advances in treatments for the management of idiopathic pulmonary fibrosis
    Sofia, Carmelo
    Comes, Alessia
    Sgalla, Giacomo
    Richeldi, Luca
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (06) : 717 - 725
  • [47] Role of RAGE in idiopathic pulmonary fibrosis: Promising prospects
    Kumar, Sukhdeep
    Jain, Neha
    Mukherjee, Tapan K.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2009, 165 (2-3) : 121 - 122
  • [48] Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis
    Njock, Makon-Sebastien
    Guiot, Julien
    Henket, Monique A.
    Nivelles, Olivier
    Thiry, Marc
    Dequiedt, Franck
    Corhay, Jean-Louis
    Louis, Renaud E.
    Struman, Ingrid
    THORAX, 2019, 74 (03) : 309 - 312
  • [49] Lung Cancer in Patients With Combined Pulmonary Fibrosis and Emphysema and Idiopathic Pulmonary Fibrosis. A Descriptive Study in a Spanish Series
    Portillo, Karina
    Perez-Rodas, Nancy
    Garcia-Olive, Ignasi
    Guasch-Arriaga, Ignasi
    Centeno, Carmen
    Serra, Pere
    Becker-Lejuez, Caroline
    Sanz-Santos, Jose
    Andreo Garcia, Felip
    Ruiz-Manzano, Juan
    ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (06): : 304 - 310
  • [50] Update on therapeutic management of idiopathic pulmonary fibrosis
    Tzouvelekis, Argyris
    Bonella, Francesco
    Spagnolo, Paolo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 359 - 370